Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Contract Pharmaceuticals Limited Canada recalls Clindamycin Phosphate

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
Products
  • Clindamycin Phosphate
Where it was sold

Nationwide in the U.S. and Puerto Rico

Nationwide

Units affected
45,875 bottles
About this recall
Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61